Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
URG101 in Pelvic Pain of Bladder Origin
NCT00517868Phase 2Terminated
- Sponsor
- Urigen Pharmaceuticals, Inc.
- Start
- Aug 2007
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of heparin + lidocaine in interstitial cystitis (IC), sponsored by Urigen Pharmaceuticals, Inc.. Started Aug 2007; status: terminated.
02
Drugs
heparin + lidocaine
03
Conditions
interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT00517868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00517868.